-
Nederlandse Vereniging voor Anesthesiologie. Richtlijn ‘Diagnostiek en behandeling van pijn bij patiënten met kanker’ 2019. www.pallialine.nl.
-
-
McCafferty M. Pain: Clinical Manual for Nursing Practice. Mosby;1989.
-
Loeser JD, Melzack R. Pain: an overview. The Lancet. 1999:1607-1609.
-
Van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016;51:1070-1090.
-
Grond S, Zech D, Diefenbach C, et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996;64:107-114.
-
Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. Pain 1999;82:263-274.
-
Roberto A, Deandrea S, Greco MT, et al. Prevalence of neuropathic pain in cancer patients: pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers. J Pain Symptom Manage 2016;51(6):1091-1102.
-
Loeser JD. Chronic pain. In Seitz FC, JCarr JE, Covey M (Eds.): Issues in behavioral medicine. Bozema, MT: Clinical Management Consultants, 1989, pp. 16-20.
-
Saunders C. The philosophy of terminal care. In: Sunders C (ed). The management of terminal malignant illness. Baltimore MD: Arnold Publishers, 1984, pp 232-241.
-
Fainsinger RL, Nekolaichuk C, Lawlor P, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010;46(16):2896-904.
-
Deandrea S, Corli O, Consonni D, et al. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76.
-
Oldenmenger WH, Stronks DL, Terwiel CTM, et al. Naar een landelijke, uniforme verpleegkundige pijnanamnese. Psychometrische kwaliteiten. Nederlands Tijdschrift voor Pijnbestrijding 2006;25(2):2-6.
-
Bouhassira D, Attal N, Alchaar H. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.
-
-
-
Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4(1):2-21. Review.
-
Bosilkovska M, Walder B, Besson M, et al. Analgesics in patients with hepatic impairment. Drugs 2012;72:1645-1669.
-
Suno M, Endo Y, Nishie H, et al. Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients.Ther Clin Risk Manag 2015;11:751-7.
-
Heiskanen T, Mätzke S, Haakana S, et al. Transdermal fentanyl in cachectic cancer patients. Pain 2009;144(1-2)218-22.
FTO Onderwerpen
FTO
